Cerebrospinal fluid biomarkers in Alzheimer's disease : from bedside to bench and back
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that results in cognitive impairment and death. The pathological hallmarks are extracellular cortical amyloid plaques and intraneuronal tangles composed of hyperphosphorylated tau. Although environmental and genetic factors contribu...
Main Author: | Paterson, R. W. |
---|---|
Other Authors: | Schott, J. M. ; Fox, N. ; Zetterberg, H. |
Published: |
University College London (University of London)
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746435 |
Similar Items
-
Origins of acetylcholinesterase in cerebrospinal fluid
by: Greenfield, S. A.
Published: (1977) -
Neurogranin-A synaptic biomarker of Alzheimer's disease
by: Wellington, Henrietta
Published: (2017) -
Circulation of the cerebrospinal fluid in the cat, with some observations on the rabbit
by: Grundy, H. F.
Published: (1966) -
Auditory scene analysis in Alzheimer's disease
by: Golden, H. L.
Published: (2016) -
Phenotypic heterogeneity and preclinical change in familial Alzheimer's disease
by: Ryan, N. S.
Published: (2017)